Enzene has announced the launch of its EnzeneX 2.0 continuous manufacturing platform for biologics at the CPHI Milan event, which takes place from 8–10 October 2024 in Milan, Italy. The technology provides fully connected, uninterrupted processing, covering the entire production
Enovo Life Sciences has been launched by industry veterans Mario Philips and Roel Gordijn in partnership with Warburg Pincus, a global growth investor. The new platform will focus on acquiring companies in the biologics and advanced therapies markets, with the
Thermo Fisher Scientific has announced its new Accelerator Drug Development platform, designed to offer 360° contract development and manufacturing organisation (CDMO) and contract research organisation (CRO) solutions to support the pharmaceutical industry. A CPHI Milan 2024, Thermo Fisher will highlight
ten23 health, a strategic CDMO is collaborating with BD (Becton, Dickinson and Company), a global medical technology company, to enhance aseptic manufacturing through the use of RFID-enabled prefillable syringes. The collaboration seeks to pilot the innovative BD iDFill™ solution, which
Synexa Life Sciences, a specialist in biomarker and bioanalysis services, has announced the acquisition of Alderley Analytical Ltd, an independent Contract Research Organisation (CRO). The acquisition took place recently, with Alderley Analytical now operating from its state-of-the-art GLP/GCP-accredited laboratory near
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd., has announced a new global licensing agreement with mAbxience, a Fresenius Kabi majority-owned group. This agreement focuses on the development of an anti-PD-1 oncology biosimilar candidate. It is the
Resilience Government Services, a subsidiary of National Resilience, has secured approximately $17.5 million in funding to bolster domestic manufacturing of essential pharmaceutical components. The funding comes from the US Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness
Amyris, a synthetic biology and industrial biotechnology company, has secured a $12.3 million agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) from the Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC). The
Sterling Pharma Solutions, a global CDMO, has entered into an agreement with biopharmaceutical company Soligenix to manufacture GMP-quality synthetic hypericin for use in the latter’s oncology drug, HyBryte. The agreement focuses on producing the compound for clinical trials, with manufacturing
In the fast-paced pharmaceutical industry, competition for talent is fierce. Many companies struggle with high turnover rates and inefficiencies due to outdated or ineffective hiring and onboarding processes not tailored for biopharma. Recent surveys reveal that: The 82% point on
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
